Dianthus Therapeutics | MGTA - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alaunos Therapeutics USD 1.29M 865K 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Celltrion KRW 435.96B 16.26T 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Moderna USD 7.41B 1.24B 2026-03
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Organon & Co USD 903M 151M 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pharma Mar EUR 249.67M 2.16M 2026-03
Qiagen NV USD 3.78B 128.73M 2025-12
Revvity USD 7.25B 125.54M 2025-12
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 14.66B 53.6M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03